These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15694536)

  • 41. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
    Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
    Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum.
    Ayoub N; Charuel JL; Diemert MC; Barete S; André M; Fermand JP; Piette JC; Francès C
    Arch Dermatol; 2004 Aug; 140(8):931-6. PubMed ID: 15313808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
    Bakoush O; Segelmark M; Torffvit O; Ohlsson S; Tencer J
    Nephrol Dial Transplant; 2006 May; 21(5):1263-9. PubMed ID: 16449276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cystic fibrosis of the child].
    Chaabouni M; Krichen A; Ben Halima N; Aloulou H; Mahfoudh A; Hachicha M; Messoud T; Fattoum S; Triki A; Karray A
    Tunis Med; 2004 Jun; 82(6):516-25. PubMed ID: 15517950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interferon system in children with cystic fibrosis].
    Badriashvili NR; Topuridze NL; Chakhunashvili GS; Tabutsadze DO; Khvtisiashvili NO
    Georgian Med News; 2006 Jul; (136):74-7. PubMed ID: 16905852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
    Emmi L; Chatzipetrou A
    Ann Ital Med Int; 2005; 20(4):205-8. PubMed ID: 16610250
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
    Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A
    Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Lebecque P; Leal T; Zylberberg K; Reychler G; Bossuyt X; Godding V
    J Cyst Fibros; 2006 Dec; 5(4):237-44. PubMed ID: 16790367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum leptin and cytokines in whole blood in relation to clinical and nutritional status in cystic fibrosis.
    Schmitt-Grohé S; Hippe V; Igel M; von Bergmann K; Posselt HG; Krahl A; Smaczny C; Wagner TO; Nikolaizik W; Lentze MJ; Zielen S
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):228-33. PubMed ID: 16877990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The emotional status of cystic fibrosis patients as evaluated by hospital and family, and the correlation of the daily treatment load to these two evaluation.
    Jørring NT; Torsson A
    Acta Univ Carol Med (Praha); 1990; 36(1-4):225-7. PubMed ID: 2130704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic inflammatory diseases in children are more severe in girls.
    Casimir GJ; Mulier S; Hanssens L; Knoop C; Ferster A; Hofman B; Duchateau J
    Shock; 2010 Jul; 34(1):23-6. PubMed ID: 20016408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secretory immunoglobulin A (sIgA) in the serum of cystic fibrosis patients.
    Hein J; Schober S; Seyfarth M; Brock J; Kirschnick HD
    Wien Klin Wochenschr; 1988 Jan; 100(2):57-9. PubMed ID: 3348043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical investigation with carbohydrate monoclonal antibodies in cystic fibrosis.
    Makovitzky J; Götze S
    Anticancer Res; 2000; 20(6D):5121-3. PubMed ID: 11326681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dermatoglyphic findings in children with mucoviscidosis and their parents].
    Stein J; Rott HD
    Anthropol Anz; 1980 May; 38(1):11-16. PubMed ID: 7425586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Circulating immunocomplexes in patients with cystic fibrosis].
    Pavluchová J; Tomásová H; Vávrová V
    Cesk Pediatr; 1984 Dec; 39(12):709-13. PubMed ID: 6440714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.